loadpatents
name:-0.042070150375366
name:-0.015377998352051
name:-0.00049304962158203
SCHOEPFER; Joseph Patent Filings

SCHOEPFER; Joseph

Patent Applications and Registrations

Patent applications and USPTO patent grants for SCHOEPFER; Joseph.The latest application filed is for "compounds and compositions for inhibiting the activity of abl1, abl2 and bcr-abl1".

Company Profile
0.21.39
  • SCHOEPFER; Joseph - Riehen CH
  • Schoepfer; Joseph - Basel N/A CH
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compounds And Compositions For Inhibiting The Activity Of Abl1, Abl2 And Bcr-abl1
App 20180134695 - FURET; Pascal ;   et al.
2018-05-17
Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1
Grant 9,896,444 - Furet , et al. February 20, 2
2018-02-20
Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1
Grant 9,458,112 - Furet , et al. October 4, 2
2016-10-04
Isoxazole Compound For The Treatment Of Cancer
App 20160220576 - Chene; Patrick ;   et al.
2016-08-04
Benzamide Derivatives For Inhibiting The Activity Of Abl1, Abl2 And Bcr-abl1
App 20160200705 - FURET; Pascal ;   et al.
2016-07-14
Compounds And Compositions For Inhibiting The Activity Of Abl1, Abl2 And Bcr-abl1
App 20160185733 - FURET; Pascal ;   et al.
2016-06-30
Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1
Grant 9,340,537 - Furet , et al. May 17, 2
2016-05-17
Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1
Grant 9,315,489 - Furet , et al. April 19, 2
2016-04-19
Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1
Grant 9,278,981 - Furet , et al. March 8, 2
2016-03-08
Isoxazole Compound For The Treatment Of Cancer
App 20160045513 - Chene; Patrick ;   et al.
2016-02-18
Compounds And Compositions For Inhibiting The Activity Of Abl1, Abl2 And Bcr-abl1
App 20150183801 - Furet; Pascal ;   et al.
2015-07-02
Compounds And Compositions For Inhibiting The Activity Of Abl1, Abl2 And Bcr-abl1
App 20150141427 - Furet; Pascal ;   et al.
2015-05-21
Benzamide Derivatives For Inhibiting The Activity Of Abl1, Abl2 And Bcr-abl1
App 20150126485 - Furet; Pascal ;   et al.
2015-05-07
Compounds And Compositions For Inhibiting The Activity Of Abl1, Abl2 And Bcr-abl1
App 20140343086 - DODD; Stephanie Kay ;   et al.
2014-11-20
Isoxazole compound for the treatment of cancer
App 20140288075 - Chene; Patrick ;   et al.
2014-09-25
Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1
Grant 8,829,195 - Dodd , et al. September 9, 2
2014-09-09
3-Methyl-imidazo[1,2-b]pyridazine derivatives
Grant 8,822,468 - Furet , et al. September 2, 2
2014-09-02
Compounds And Compositions For Inhibiting The Activity Of Abl1, Abl2 And Bcr-abl1
App 20130310395 - DODD; Stephanie Kay ;   et al.
2013-11-21
Compounds and compositions as protein kinase inhibitors
Grant 8,552,002 - Ding , et al. October 8, 2
2013-10-08
3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
Grant 8,389,526 - Furet , et al. March 5, 2
2013-03-05
Compounds And Compositions As Protein Kinase Inhibitors
App 20130012476 - DING; Qiang ;   et al.
2013-01-10
Compounds And Compositions As Protein Kinase Inhibitors
App 20130012704 - DING; Qiang ;   et al.
2013-01-10
Isoxazole Compound For The Treatment Of Cancer
App 20120214813 - Chene; Patrick ;   et al.
2012-08-23
Organic compounds
Grant 8,217,045 - Manley , et al. July 10, 2
2012-07-10
Isoxazole Compound For The Treatment Of Cancer
App 20120083496 - CHENE; Patrick ;   et al.
2012-04-05
3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl Derivatives
App 20110039831 - Furet; Pascal ;   et al.
2011-02-17
Substituted imidazopyridazines and pyrrolopyrimidines as lipid kinase inhibitors
App 20100311729 - Capraro; Hans-Georg ;   et al.
2010-12-09
Thiazole and pyrazole derivatives as Flt-3 kinase inhibitors
Grant 7,795,288 - Bold , et al. September 14, 2
2010-09-14
Isoxazole Compound For The Treatment Of Cancer
App 20100210650 - Chene; Patrick ;   et al.
2010-08-19
Organic Compounds
App 20100113467 - Manley; Paul W. ;   et al.
2010-05-06
3-methyl-imidazo[1,2-b]pyridazine Derivatives
App 20090264406 - Furet; Pascal ;   et al.
2009-10-22
Compounds and Compositions as Protein Kinase Inhibitors
App 20090137804 - Ding; Qiang ;   et al.
2009-05-28
Inhibitors Of Hsp90
App 20090069341 - Chene; Patrick ;   et al.
2009-03-12
Inhibitors of HSP90
App 20090039811 - Chene; Patrick ;   et al.
2009-02-12
Radicicol Derivatives Useful for Position Emission Tomography
App 20080311038 - Auberson; Yves ;   et al.
2008-12-18
Use of 9H-Purine-2,6-Diamine Derivatives in the Treatment of Proliferative Diseases and Novel 9H-Purine-2,6-Diamine Derivatives
App 20070249639 - Baenteli; Rolf ;   et al.
2007-10-25
Thiazole and pyrazole derivatives as flt-3 kinase inhibitors
App 20070167449 - Bold; Guido ;   et al.
2007-07-19
Methods and compositions as protein kinase inhibitors
Grant 7,189,729 - Chopiuk , et al. March 13, 2
2007-03-13
Methods of screening for compounds which inhibit the activity of Cdc34 in a zinc-mediated manner and compounds obtained by this method
App 20060211747 - Furet; Pascal ;   et al.
2006-09-21
Methods and compositions as protein kinase inhibitors
App 20050171105 - Chopiuk, Greg ;   et al.
2005-08-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed